Revelation Biosciences, Inc. SEC filings REVBW
Revelation Biosciences, Inc. has 389 filings in SEC EDGAR's recent list, going back to May 14, 2020. Its latest annual report, Form ARS, was filed on May 11, 2026 for the period ended May 11, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | May 11, 2026 | May 11, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 6, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Sep 23, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 22, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Apr 15, 2022 | Dec 31, 2021 |
| 10-K/A | Amended annual report | Jun 16, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 31, 2021 | Dec 31, 2020 |
Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- REVB (Nasdaq), REVBW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1810560
- Former names
- Petra Acquisition Inc. (until Jan 11, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.